| Year |
Citation |
Score |
| 2020 |
Drake LR, Brooks AF, Stauff J, Sherman PS, Arteaga J, Koeppe RA, Reed A, Montavon TJ, Skaddan MB, Scott PJH. Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE). Journal of Pharmaceutical Analysis. 10: 452-465. PMID 33133729 DOI: 10.1016/J.Jpha.2020.07.009 |
0.367 |
|
| 2020 |
Kanel P, Müller MLTM, van der Zee S, Sanchez-Catasus CA, Koeppe RA, Frey KA, Bohnen NI. Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych190701. PMID 32498602 DOI: 10.1176/Appi.Neuropsych.19070165 |
0.357 |
|
| 2020 |
Kramer V, Brooks AF, Haeger A, Kuljs RO, Rafique W, Koeppe RA, Raffel DM, Frey KA, Amaral H, Scott PJH, Riss PJ. Evaluation of [F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies. Acs Chemical Neuroscience. PMID 31898886 DOI: 10.1021/Acschemneuro.9B00639 |
0.352 |
|
| 2019 |
Drake LR, Pham JM, Desmond TJ, Mossine AV, Lee SJ, Kilbourn MR, Koeppe RA, Brooks AF, Scott PJH. Identification of AV-1451 as a Weak, Nonselective Inhibitor of Monoamine Oxidase. Acs Chemical Neuroscience. PMID 31339297 DOI: 10.1021/Acschemneuro.9B00326 |
0.359 |
|
| 2019 |
Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM. Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology. PMID 30720884 DOI: 10.1002/Ana.25430 |
0.373 |
|
| 2018 |
Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/Cne.24541 |
0.337 |
|
| 2018 |
Kilbourn MR, Koeppe RA. Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2. Acs Chemical Neuroscience. 10: 25-29. PMID 30198706 DOI: 10.1021/Acschemneuro.8B00429 |
0.348 |
|
| 2018 |
Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry. PMID 30082840 DOI: 10.1038/S41380-018-0130-5 |
0.356 |
|
| 2018 |
Chiao P, Bedell BJ, Avants B, Zijdenbos AP, Grand'Maison M, O'Neill P, O'Gorman J, Chen T, Koeppe R. Impact of Reference/Target Region Selection on Amyloid PET Standard Uptake Value Ratios in the Phase 1b PRIME Study of Aducanumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29777003 DOI: 10.2967/Jnumed.118.209130 |
0.376 |
|
| 2018 |
Sowa AR, Brooks AF, Shao X, Henderson BD, Sherman PS, Arteaga J, Stauff J, Lee AC, Koeppe RA, Scott PJH, Kilbourn MR. Development of Positron Emission Tomography (PET) Radiotracers for the GABA Transporter 1 (GAT-1). Acs Chemical Neuroscience. PMID 29763549 DOI: 10.1021/Acschemneuro.8B00183 |
0.341 |
|
| 2017 |
Kilbourn MR, Koeppe RA. A six-year longitudinal PET study of (+)-[C]DTBZ binding to the VMAT2 in monkey brain. Nuclear Medicine and Biology. 55: 34-37. PMID 29031997 DOI: 10.1016/J.Nucmedbio.2017.08.008 |
0.34 |
|
| 2017 |
Blecha JE, Henderson BD, Hockley BG, VanBrocklin HF, Zubieta JK, DaSilva AF, Kilbourn MR, Koeppe RA, Scott PJH, Shao X. An Updated Synthesis of [(11) C]Carfentanil for Positron Emission Tomography (PET) Imaging of the μ-Opioid Receptor. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28419528 DOI: 10.1002/Jlcr.3513 |
0.323 |
|
| 2017 |
Joseph-Mathurin N, Su Y, Blazey T, Jasielec MS, Vlassenko AG, Friedrichsen KA, Gordon BA, Hornbeck RC, Cash L, Ances BM, Raichle ME, Brickman AM, Buckles V, Cairns NJ, Cruchaga C, ... ... Koeppe RA, et al. Utility Of Perfusion Pet Models As Measures Of Neurodegeneration In An Autosomal Dominant Alzheimer’S Disease Population: Report From The Dian Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1027 |
0.328 |
|
| 2016 |
Saccone PA, Lindsey AM, Koeppe RA, Zelenock KA, Shao X, Sherman P, Quesada CA, Woods JH, Scott PJ. Intranasal opioid administration in rhesus monkeys: PET imaging and antinociception. The Journal of Pharmacology and Experimental Therapeutics. PMID 27625351 DOI: 10.1124/Jpet.116.235192 |
0.324 |
|
| 2016 |
Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. Acs Medicinal Chemistry Letters. 7: 746-50. PMID 27563397 DOI: 10.1021/Acsmedchemlett.5B00435 |
0.363 |
|
| 2016 |
Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082 |
0.368 |
|
| 2016 |
Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26911386 DOI: 10.1007/S00702-016-1524-7 |
0.312 |
|
| 2016 |
Benzinger TLS, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, et al. Tau Pet Imaging With Av-1451 In Autosomal Dominant Alzheimer'S Disease: Update From The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12: 378. DOI: 10.1016/J.Jalz.2016.06.709 |
0.356 |
|
| 2015 |
Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, et al. Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials. Neurology. PMID 26208959 DOI: 10.1212/Wnl.0000000000001877 |
0.328 |
|
| 2015 |
Jagust WJ, Landau SM, Koeppe RA, Reiman EM, Chen K, Mathis CA, Price JC, Foster NL, Wang AY. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 757-71. PMID 26194311 DOI: 10.1016/J.Jalz.2015.05.001 |
0.384 |
|
| 2015 |
Albin RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, Burke JF, Camelo-Piragua S, Lieberman AP, Giordani B, Frey KA. Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Annals of Neurology. PMID 26183692 DOI: 10.1002/Ana.24481 |
0.354 |
|
| 2015 |
Shu H, Nan B, Koeppe R. Multiple testing for neuroimaging via hidden Markov random field. Biometrics. 71: 741-50. PMID 26012881 DOI: 10.1111/Biom.12329 |
0.341 |
|
| 2015 |
Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 567-74. PMID 25745095 DOI: 10.2967/Jnumed.114.148981 |
0.362 |
|
| 2015 |
Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N, Protas H, Luo JL, Bauer R, Reschke C, Bandy D, Koeppe RA, Fleisher AS, Caselli RJ, Landau S, et al. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 560-6. PMID 25745091 DOI: 10.2967/Jnumed.114.149732 |
0.308 |
|
| 2015 |
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1-15.e1-4. PMID 25443857 DOI: 10.1016/J.Jalz.2014.07.003 |
0.362 |
|
| 2015 |
Joseph-Mathurin N, Su Y, Vlassenko A, Jasielec MS, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Stevenson TA, Cash L, Xiong C, Ringman JM, Brickman AM, Koeppe RA, Ances B, et al. IC-03-02: Early frame of PiB and FDG in autosomal dominant Alzheimer's disease: Similarity, discrepancy, and clinical implication Alzheimer's & Dementia. 11: P8-P9. DOI: 10.1016/J.Jalz.2015.06.013 |
0.324 |
|
| 2014 |
Wang X, Nan B, Zhu J, Koeppe R. REGULARIZED 3D FUNCTIONAL REGRESSION FOR BRAIN IMAGE DATA VIA HAAR WAVELETS. The Annals of Applied Statistics. 8: 1045-1064. PMID 26082826 DOI: 10.1214/14-Aoas736 |
0.338 |
|
| 2014 |
Schmidt ME, Chiao P, Klein G, Matthews D, Thurfjell L, Cole PE, Margolin R, Landau S, Foster NL, Mason NS, De Santi S, Suhy J, Koeppe RA, Jagust W. The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25457431 DOI: 10.1016/J.Jalz.2014.09.004 |
0.373 |
|
| 2014 |
Nascimento TD, DosSantos MF, Lucas S, van Holsbeeck H, DeBoer M, Maslowski E, Love T, Martikainen IK, Koeppe RA, Smith YR, Zubieta JK, DaSilva AF. μ-Opioid activation in the midbrain during migraine allodynia - brief report II. Annals of Clinical and Translational Neurology. 1: 445-50. PMID 25328905 DOI: 10.1002/Acn3.66 |
0.327 |
|
| 2014 |
Chou KL, Lenhart A, Koeppe RA, Bohnen NI. Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. Parkinsonism & Related Disorders. 20: 1076-80. PMID 25085750 DOI: 10.1016/J.Parkreldis.2014.07.008 |
0.306 |
|
| 2014 |
Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, Koeppe RA, Albin RL. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 690-703. PMID 25022534 DOI: 10.1016/J.Jalz.2014.04.513 |
0.313 |
|
| 2014 |
DaSilva AF, Nascimento TD, Love T, DosSantos MF, Martikainen IK, Cummiford CM, DeBoer M, Lucas SR, Bender MA, Koeppe RA, Hall T, Petty S, Maslowski E, Smith YR, Zubieta JK. 3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache. Journal of Visualized Experiments : Jove. PMID 24962460 DOI: 10.3791/50682 |
0.341 |
|
| 2014 |
Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1118-24. PMID 24909584 DOI: 10.1002/Mds.25929 |
0.375 |
|
| 2014 |
Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/Jnumed.113.124792 |
0.33 |
|
| 2014 |
Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S, Inlow M, Foroud T, Jagust WJ, Koeppe RA, Mathis CA, Shaw LM, Trojanowski JQ, Soares H, Aisen PS, et al. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: e9-e18. PMID 23541187 DOI: 10.1016/J.Jalz.2013.01.007 |
0.322 |
|
| 2014 |
Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L, Foroud TM, Hakonarson H, Huentelman MJ, Aisen PS, Petersen RC, Green RC, Jack CR, Koeppe RA, Jagust WJ, et al. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Molecular Psychiatry. 19: 351-7. PMID 23419831 DOI: 10.1038/Mp.2013.19 |
0.354 |
|
| 2013 |
Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110 |
0.387 |
|
| 2013 |
Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 81: 1611-6. PMID 24078735 DOI: 10.1212/Wnl.0B013E3182A9F558 |
0.305 |
|
| 2013 |
Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain : a Journal of Neurology. 136: 3282-9. PMID 24056537 DOI: 10.1093/Brain/Awt247 |
0.347 |
|
| 2013 |
Fabiilli ML, Piert MR, Koeppe RA, Sherman PS, Quesada CA, Kripfgans OD. Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats. Contrast Media & Molecular Imaging. 8: 366-74. PMID 23613440 DOI: 10.1002/Cmmi.1532 |
0.343 |
|
| 2013 |
Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 887-93. PMID 23572495 DOI: 10.2967/Jnumed.112.112599 |
0.395 |
|
| 2013 |
Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, Petersen RC, Jack CR, Aisen PS, Koeppe RA, Jagust WJ, Shaw LM, Trojanowski JQ, Weiner MW, Saykin AJ, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Frontiers in Aging Neuroscience. 5: 11. PMID 23554593 DOI: 10.3389/Fnagi.2013.00011 |
0.319 |
|
| 2013 |
Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1421-4. PMID 23532360 DOI: 10.1007/S00702-013-1013-1 |
0.32 |
|
| 2013 |
Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 296-301. PMID 23239424 DOI: 10.1002/Mds.25213 |
0.335 |
|
| 2013 |
Chen K, Stonnington C, Ayutyanont N, Reschke C, Thyyagura P, Protas H, Liu X, Roontiva A, Parks S, Bauer R, Lee W, Koeppe R, Jagust W, Foster N, Weiner M, et al. Baseline FDG-PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study Alzheimers & Dementia. 9: 844. DOI: 10.1016/J.Jalz.2013.08.007 |
0.322 |
|
| 2013 |
Protas H, Chen K, Reschke C, Roontiva A, Liu X, Parks S, Lee W, Bauer R, Ayutyanont N, Thiyyagura P, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 68. DOI: 10.1016/J.Jalz.2013.05.109 |
0.325 |
|
| 2013 |
Margolin R, Schmidt M, Gregg K, Les A, Hill D, Koeppe R, Wyman B, Styren S, Grundman M, Yuen E, Brashear RH, Liu E. Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials Alzheimers & Dementia. 9: 18. DOI: 10.1016/J.Jalz.2013.05.016 |
0.356 |
|
| 2013 |
Roontiva A, Chen K, Ayutyanont N, Protas H, Liu X, Thiyyagura P, Lee W, Reschke C, Parks S, Bauer R, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Association between the Alzheimer's disease-related hypometabolic convergence index and clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative Alzheimers & Dementia. 9: 698. DOI: 10.1016/J.Jalz.2013.04.377 |
0.329 |
|
| 2012 |
Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology. 72: 578-86. PMID 23109153 DOI: 10.1002/Ana.23650 |
0.388 |
|
| 2012 |
Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL. Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Archives of Neurology. 69: 1628-31. PMID 22964894 DOI: 10.1001/Archneurol.2012.764 |
0.361 |
|
| 2012 |
Petrou M, Bohnen NI, Müller ML, Koeppe RA, Albin RL, Frey KA. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 79: 1161-7. PMID 22933741 DOI: 10.1212/Wnl.0B013E3182698D4A |
0.381 |
|
| 2012 |
Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. Plos One. 7: e40166. PMID 22792235 DOI: 10.1371/Journal.Pone.0040166 |
0.314 |
|
| 2012 |
Ikari Y, Nishio T, Makishi Y, Miya Y, Ito K, Koeppe RA, Senda M. Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study. Annals of Nuclear Medicine. 26: 535-44. PMID 22763629 DOI: 10.1007/S12149-012-0605-4 |
0.377 |
|
| 2012 |
Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/Jcbfm.2012.60 |
0.357 |
|
| 2012 |
Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Annals of Neurology. 71: 560-8. PMID 22522445 DOI: 10.1002/Ana.22691 |
0.34 |
|
| 2012 |
Kotagal V, Müller ML, Kaufer DI, Koeppe RA, Bohnen NI. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neuroscience Letters. 514: 169-72. PMID 22414859 DOI: 10.1016/J.Neulet.2012.02.083 |
0.34 |
|
| 2012 |
Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0 |
0.325 |
|
| 2012 |
Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, et al. Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging and Behavior. 6: 1-15. PMID 21901424 DOI: 10.1007/S11682-011-9136-1 |
0.362 |
|
| 2012 |
Lenhart A, Bohnen N, Koeppe R, Chou K. Dopaminergic and Cholinergic Brain Activity and Performance on MMSE and MoCA in Parkinson's Disease (P03.127) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.127 |
0.373 |
|
| 2012 |
Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655 |
0.346 |
|
| 2012 |
Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132 |
0.364 |
|
| 2012 |
Risacher S, Kim S, Shen L, Ngo K, Foroud T, Petersen R, Aisen P, Jack C, Koeppe R, Jagust W, Weiner M, Saykin A. IC-P-098: The role of APOE-ɛ4 genotype in early mild cognitive impairment (EMCI): Preliminary results from ADNI-2 Alzheimer's & Dementia. 8: P56-P57. DOI: 10.1016/J.Jalz.2012.05.131 |
0.303 |
|
| 2012 |
Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064 |
0.333 |
|
| 2012 |
Protas H, Chen K, Reschke C, Roontiva A, Lee W, Nishimura M, Ayutyanont N, Liu X, Thiyyagura P, Parks S, Koeppe R, Jagust W, Foster N, Weiner M, Fleisher A, et al. Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares Alzheimers & Dementia. 8: 20. DOI: 10.1016/J.Jalz.2012.05.056 |
0.351 |
|
| 2012 |
Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052 |
0.333 |
|
| 2011 |
Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/Brain/Awr139 |
0.319 |
|
| 2011 |
Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/Jnumed.111.089946 |
0.382 |
|
| 2011 |
Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/Brain/Awr089 |
0.379 |
|
| 2011 |
Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Shaw L, Trojanowski JQ, Jack CR, Landau SM, Foster NL, ... ... Koeppe RA, et al. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage. 56: 52-60. PMID 21276856 DOI: 10.1016/J.Neuroimage.2011.01.049 |
0.377 |
|
| 2011 |
Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, ... ... Koeppe RA, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Archives of Neurology. 68: 329-37. PMID 21059987 DOI: 10.1001/Archneurol.2010.295 |
0.406 |
|
| 2011 |
Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging. 32: 1207-18. PMID 19660834 DOI: 10.1016/J.Neurobiolaging.2009.07.002 |
0.377 |
|
| 2011 |
Gilman S, Giordani B, Albin R, Koeppe R, Burke J, Kilbourn M, Frey K. Mild Dementia evaluated with [11C]DTBZ and [11C]PiB positron emission tomography Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.277 |
0.327 |
|
| 2011 |
Ayutyanont N, Chen K, Roontiva A, Fleisher A, Langbaum J, Reschke C, Lee W, Liu X, Bandy D, Alexander G, Foster N, Harvey D, Weiner M, Koeppe R, Jagust W, et al. Use of an FDG-PET derived hypometabolic convergence index enrichment strategy to reduce sample sizes in Alzheimer's disease clinical trials: findings from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.150 |
0.361 |
|
| 2010 |
Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, et al. Validation of consensus panel diagnosis in dementia. Archives of Neurology. 67: 1506-12. PMID 21149812 DOI: 10.1001/Archneurol.2010.301 |
0.314 |
|
| 2010 |
Wu X, Chen K, Yao L, Ayutyanont N, Langbaum JB, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Foster NL, Thompson PM, Harvey DJ, Weiner MW, ... Koeppe RA, et al. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192: 277-85. PMID 20678521 DOI: 10.1016/J.Jneumeth.2010.07.030 |
0.405 |
|
| 2010 |
Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-303. PMID 20538372 DOI: 10.1016/J.Neurobiolaging.2010.05.003 |
0.305 |
|
| 2010 |
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 221-9. PMID 20451870 DOI: 10.1016/J.Jalz.2010.03.003 |
0.421 |
|
| 2010 |
Gilman S, Koeppe RA, Nan B, Wang CN, Wang X, Junck L, Chervin RD, Consens F, Bhaumik A. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology. 74: 1416-23. PMID 20439843 DOI: 10.1212/Wnl.0B013E3181Dc1A55 |
0.322 |
|
| 2010 |
Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 133: 1747-54. PMID 20413575 DOI: 10.1093/Brain/Awq079 |
0.379 |
|
| 2010 |
Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/Archneurol.2010.34 |
0.403 |
|
| 2010 |
Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, et al. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage. 51: 654-64. PMID 20202480 DOI: 10.1016/J.Neuroimage.2010.02.064 |
0.396 |
|
| 2010 |
Galbán CJ, Bhojani MS, Lee KC, Meyer CR, Van Dort ME, Kuszpit KK, Koeppe RA, Ranga R, Moffat BA, Johnson TD, Chenevert TL, Rehemtulla A, Ross BD. Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1542-52. PMID 20160061 DOI: 10.1158/1078-0432.Ccr-08-1812 |
0.321 |
|
| 2010 |
Chen K, Ayutyanont N, Langbaum J, Fleisher A, Reschke C, Lee W, Liu X, Alexander GE, Bandy D, Yu M, Foster NL, Weiner MW, Thompson PM, Koeppe RA, Jagust WJ, et al. Use of an Alzheimer's Disease-Related Hypometabolic Convergence Index to Predict Progression from Mild Cognitive Impairment to Alzheimer's Dementia Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.971 |
0.321 |
|
| 2009 |
Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 73: 1670-6. PMID 19917989 DOI: 10.1212/Wnl.0B013E3181C1Ded6 |
0.316 |
|
| 2009 |
Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM, Foster NL, Petersen RC, Weiner MW, Price JC, Mathis CA. Relationships between biomarkers in aging and dementia. Neurology. 73: 1193-9. PMID 19822868 DOI: 10.1212/Wnl.0B013E3181Bc010C |
0.398 |
|
| 2009 |
Kilbourn MR, Hockley B, Lee L, Sherman P, Quesada C, Frey KA, Koeppe RA. Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter Nuclear Medicine and Biology. 36: 489-493. PMID 19520289 DOI: 10.1016/J.Nucmedbio.2009.02.007 |
0.33 |
|
| 2009 |
Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage. 46: 154-9. PMID 19457369 DOI: 10.1016/J.Neuroimage.2009.01.057 |
0.379 |
|
| 2009 |
Joshi AD, Koeppe RA, Fessler JA, Kilbourn MR. Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approaches Journal of Cerebral Blood Flow and Metabolism. 29: 1346-1357. PMID 19401708 DOI: 10.1038/Jcbfm.2009.53 |
0.344 |
|
| 2009 |
Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/Wnl.0B013E3181A187Dd |
0.32 |
|
| 2009 |
Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 45: 1107-16. PMID 19349228 DOI: 10.1016/J.Neuroimage.2008.12.072 |
0.429 |
|
| 2009 |
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320 |
0.346 |
|
| 2008 |
Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S67-76. PMID 18632004 DOI: 10.1016/J.Jalz.2007.11.016 |
0.365 |
|
| 2008 |
Foster NL, Wang AY, Tasdizen T, Fletcher PT, Hoffman JM, Koeppe RA. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S29-36. PMID 18631997 DOI: 10.1016/J.Jalz.2007.10.004 |
0.389 |
|
| 2008 |
Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, Drzezga A, Stern Y. Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage. 40: 1503-15. PMID 18343688 DOI: 10.1016/J.Neuroimage.2008.01.056 |
0.356 |
|
| 2008 |
Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 441-4. PMID 18073772 DOI: 10.1038/Sj.Jcbfm.9600599 |
0.311 |
|
| 2008 |
Chen K, Lee W, Liu X, Alexander G, Bandy D, Reschke C, Foster N, Weiner M, Koeppe R, Jagust W, Reiman E. P1-338: The consistency of hypometabolic brain voxels in probable Alzheimer's disease and amnestic mild cognitive impairment patients from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T318-T318. DOI: 10.1016/J.Jalz.2008.05.919 |
0.35 |
|
| 2008 |
Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. P1-312: Differentiating amnestic mild cognitive impairment converting to probable Alzheimer's disease from stable amnestic mild cognitive impairment using FDG-PET and an Alzheimer's disease-related hypometabolism overlap index Alzheimer's & Dementia. 4: T312-T312. DOI: 10.1016/J.Jalz.2008.05.903 |
0.362 |
|
| 2008 |
Landau SM, Madison C, Wu D, Cheung C, Foster N, Reiman E, Koeppe R, Weiner M, Jagust WJ. P1-258: Pinpointing change in Alzheimer's disease: Longitudinal FDG-PET analyses from the Alzheimer's disease neuroimaging initiative Alzheimer's & Dementia. 4: T291-T292. DOI: 10.1016/J.Jalz.2008.05.848 |
0.372 |
|
| 2008 |
Madison C, Landau S, Cheung C, Lal R, Foster N, Reiman E, Koeppe R, Weiner M, Jagust W. IC-P2-114: Meta-analysis ROIs and minimal deformation templates improve PET-FDG as a candidate biomarker in Alzheimer's disease Alzheimer's & Dementia. 4: T53-T53. DOI: 10.1016/J.Jalz.2008.05.2569 |
0.412 |
|
| 2008 |
Chen K, Reschke C, Lee W, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P2-086: The pattern of cerebral hypometablism in amnestic mild cognitive impairment and its relationship to subsequent conversion to probable Alzheimer's disease: Preliminary findings from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.079 |
0.331 |
|
| 2008 |
Ayutyanont N, Chen K, Liu X, Reschke C, Lee W, Bandy D, Alexander GE, Jagust WJ, Koeppe RA, Foster NL, Reiman EM. IC-P2-074: Differentiating amnestic MCI converting to probable AD from stable amnestic MCI using FDG-PET and an AD-related hypometabolism overlap index Alzheimer's & Dementia. 4: T38-T38. DOI: 10.1016/J.Jalz.2008.05.067 |
0.336 |
|
| 2008 |
Lee W, Langbaum JBS, Chen K, Recshke C, Bandy D, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM. IC-P1-036: Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's disease neuroimaging initiative Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.047 |
0.366 |
|
| 2007 |
Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a Journal of Neurology. 130: 2616-35. PMID 17704526 DOI: 10.1093/Brain/Awm177 |
0.386 |
|
| 2007 |
Scott DJ, Stohler CS, Koeppe RA, Zubieta JK. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge. Synapse (New York, N.Y.). 61: 707-14. PMID 17559096 DOI: 10.1002/Syn.20404 |
0.321 |
|
| 2007 |
Chen K, Reiman EM, Alexander GE, Smilovici O, Lee W, Reschke C, Bandy D, Foster NL, Weiner MW, Koeppe RA, Jagust WJ. P-024: The pattern and severity of FDG pet abnormalities in Alzheimer’s disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer’s disease neuroimaging initiative Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.240 |
0.373 |
|
| 2006 |
Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology. 185: 327-38. PMID 16518646 DOI: 10.1007/S00213-006-0330-6 |
0.314 |
|
| 2006 |
Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1198-212. PMID 16421508 DOI: 10.1038/Sj.Jcbfm.9600276 |
0.333 |
|
| 2006 |
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672 |
0.375 |
|
| 2005 |
Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, Dekosky ST, Moore RY. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 315-9. PMID 15716518 DOI: 10.1136/Jnnp.2004.038729 |
0.375 |
|
| 2005 |
Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers Bioorganic and Medicinal Chemistry. 13: 869-875. PMID 15653352 DOI: 10.1016/J.Bmc.2004.10.034 |
0.341 |
|
| 2005 |
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing. Experimental Neurology. 191: S95-S103. PMID 15629765 DOI: 10.1016/J.Expneurol.2004.06.017 |
0.384 |
|
| 2005 |
Koeppe RA, Gilman S, Junck L, Heumann M, Wernette K, Frey KA. Differentiation of Lewy body dementia from Parkinson's disease with [C-11]DTBZ PET Journal of Cerebral Blood Flow & Metabolism. 25: S393-S393. DOI: 10.1038/Sj.Jcbfm.9591524.0393 |
0.363 |
|
| 2004 |
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Annals of Neurology. 55: 774-80. PMID 15174011 DOI: 10.1002/Ana.20088 |
0.359 |
|
| 2004 |
Moretti P, Lieberman AP, Wilde EA, Giordani BI, Kluin KJ, Koeppe RA, Minoshima S, Kuhl DE, Seltzer WK, Foster NL. Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis. Neurology. 62: 1865-8. PMID 15159497 DOI: 10.1212/01.Wnl.0000126447.91111.A1 |
0.329 |
|
| 2004 |
Lucignani G, Panzacchi A, Bosio L, Moresco RM, Ravasi L, Coppa I, Chiumello G, Frey K, Koeppe R, Fazio F. GABAA receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil Neuroimage. 22: 22-28. PMID 15109994 DOI: 10.1016/J.Neuroimage.2003.10.050 |
0.31 |
|
| 2004 |
Ma B, Sherman PS, Moskwa JE, Koeppe RA, Kilbourn MR. Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([ 11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods Nuclear Medicine and Biology. 31: 393-397. PMID 15093808 DOI: 10.1016/J.Nucmedbio.2003.12.009 |
0.318 |
|
| 2004 |
Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Statistics in Medicine. 23: 315-26. PMID 14716732 DOI: 10.1002/Sim.1719 |
0.398 |
|
| 2004 |
Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K. P3-395 A comparison of FDG-PET and neuropsychological testing in differentiating Alzheimer's disease from dementia with lewy bodies Neurobiology of Aging. 25: S467. DOI: 10.1016/S0197-4580(04)81543-4 |
0.374 |
|
| 2004 |
Foster NL, Barbas NR, Heidebrink JL, Scott Turner R, Clark CM, Jagust WJ, Arnold SE, DeCarli CS, Koeppe RA, Higdon R. P3-070 Adding FDG-PET to clinical history and examination improves the accuracy of dementia diagnosis Neurobiology of Aging. 25: S372. DOI: 10.1016/S0197-4580(04)81222-3 |
0.351 |
|
| 2004 |
Heidebrink JL, Barbas NR, Scott Turner R, Clark CM, Jagust WJ, Arnold SE, DeCarli CS, Koeppe RA, Higdon R, Foster NL. P3-065 FDG-PET improves differential diagnosis of dementia when clinical history and examination are ambiguous Neurobiology of Aging. 25: S370-S371. DOI: 10.1016/S0197-4580(04)81217-X |
0.34 |
|
| 2003 |
Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, DeKosky ST. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Archives of Neurology. 60: 1745-8. PMID 14676050 DOI: 10.1001/Archneur.60.12.1745 |
0.368 |
|
| 2003 |
Thomas CT, Meyer CR, Koeppe RA, Kalemkerian GP, Fisher SJ, Dull TL, Zasadny KR, Wahl RL. A positron-emitting internal marker for identification of normal tissue by positron emission tomography: phantom studies and validation in patients. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 79-85. PMID 14499148 DOI: 10.1016/S1536-1632(03)00043-X |
0.355 |
|
| 2003 |
Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.Wnl.0000076181.39162.Fc |
0.325 |
|
| 2003 |
Gilman S, Chervin RD, Koeppe RA, Consens FB, Little R, An H, Junck L, Heumann M. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology. 61: 35-9. PMID 12847153 DOI: 10.1212/01.Wnl.0000073624.13436.32 |
0.301 |
|
| 2003 |
Thomas CT, Meyer CR, Koeppe RA, Kalemkerian GP, Fisher SJ, Dull TL, Zasadny KR, Wahl RL. "A Positron-emitting internal marker for identification of normal tissue by positron emission tomography: Phantom studies and validation in Patients," (Molecular Imaging and Biology (2003) vol. 5 (2) 79-85)) Molecular Imaging and Biology. 5: 278-279. DOI: 10.1016/S1536-1632(03)00109-4 |
0.327 |
|
| 2002 |
Liberzon I, Zubieta JK, Fig LM, Phan KL, Koeppe RA, Taylor SF. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proceedings of the National Academy of Sciences of the United States of America. 99: 7084-9. PMID 12011464 DOI: 10.1073/Pnas.102174799 |
0.308 |
|
| 2001 |
Patalano AL, Smith EE, Jonides J, Koeppe RA. PET evidence for multiple strategies of categorization. Cognitive, Affective & Behavioral Neuroscience. 1: 360-70. PMID 12467087 DOI: 10.3758/Cabn.1.4.360 |
0.306 |
|
| 2001 |
Koeppe RA, Raffel DM, Snyder SE, Ficaro EP, Kilbourn MR, Kuhl DE. Dual-[11C]tracer single-acquisition positron emission tomography studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 1480-92. PMID 11740210 DOI: 10.1097/00004647-200112000-00013 |
0.357 |
|
| 2001 |
Snyder SE, Gunupudi N, Sherman PS, Butch ER, Skaddan MB, Kilbourn MR, Koeppe RA, Kuhl DE. Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 21: 132-43. PMID 11176278 DOI: 10.1097/00004647-200102000-00004 |
0.318 |
|
| 2001 |
Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (New York, N.Y.). 39: 275-87. PMID 11169777 DOI: 10.1002/1098-2396(20010315)39:4<275::Aid-Syn1010>3.0.Co;2-3 |
0.375 |
|
| 2001 |
Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry. 49: 110-6. PMID 11164757 DOI: 10.1016/S0006-3223(00)00981-1 |
0.322 |
|
| 2000 |
Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA, Cross DJ, Zubieta J. Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience. 101: 277-82. PMID 11074150 DOI: 10.1016/S0306-4522(00)00357-2 |
0.313 |
|
| 2000 |
Liberzon I, Taylor SF, Fig LM, Decker LR, Koeppe RA, Minoshima S. Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 508-16. PMID 11027916 DOI: 10.1016/S0893-133X(00)00157-3 |
0.32 |
|
| 2000 |
Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA, Zubieta JK. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse (New York, N.Y.). 38: 313-21. PMID 11020234 DOI: 10.1002/1098-2396(20001201)38:3<313::Aid-Syn10>3.0.Co;2-6 |
0.302 |
|
| 2000 |
Zubieta JK, Huguelet P, Ohl LE, Koeppe RA, Kilbourn MR, Carr JM, Giordani BJ, Frey KA. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. The American Journal of Psychiatry. 157: 1619-28. PMID 11007716 DOI: 10.1176/Appi.Ajp.157.10.1619 |
0.303 |
|
| 2000 |
Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Annals of Neurology. 48: 391-5. PMID 10976649 DOI: 10.1002/1531-8249(200009)48:3<391::Aid-Ana17>3.0.Co;2-H |
0.346 |
|
| 2000 |
Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/Wnl.54.9.1753 |
0.354 |
|
| 1999 |
Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1376-84. PMID 10598942 DOI: 10.1097/00004647-199912000-00011 |
0.351 |
|
| 1999 |
Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1150-63. PMID 10532640 DOI: 10.1097/00004647-199910000-00012 |
0.319 |
|
| 1999 |
Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/Wnl.53.2.371 |
0.31 |
|
| 1999 |
Gilman S, Koeppe RA, Junck L, Little R, Kluin KJ, Heumann M, Martorello S, Johanns J. Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Annals of Neurology. 45: 769-77. PMID 10360769 DOI: 10.1002/1531-8249(199906)45:6<769::Aid-Ana11>3.0.Co;2-G |
0.361 |
|
| 1999 |
Berent S, Giordani B, Foster N, Minoshima S, Lajiness-O'Neill R, Koeppe R, Kuhl DE. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. Journal of Psychiatric Research. 33: 7-16. PMID 10094234 DOI: 10.1016/S0022-3956(98)90048-6 |
0.382 |
|
| 1999 |
Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/Wnl.52.4.691 |
0.367 |
|
| 1998 |
Jonides J, Smith EE, Marshuetz C, Koeppe RA, Reuter-Lorenz PA. Inhibition in verbal working memory revealed by brain activation. Proceedings of the National Academy of Sciences of the United States of America. 95: 8410-3. PMID 9653200 DOI: 10.1073/Pnas.95.14.8410 |
0.303 |
|
| 1998 |
Jonides J, Schumacher EH, Smith EE, Koeppe RA, Awh E, Reuter-Lorenz PA, Marshuetz C, Willis CR. The role of parietal cortex in verbal working memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5026-34. PMID 9634568 DOI: 10.1523/Jneurosci.18-13-05026.1998 |
0.317 |
|
| 1998 |
Zubieta JK, Koeppe RA, Mulholland GK, Kuhl DE, Frey KA. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 619-31. PMID 9626186 DOI: 10.1097/00004647-199806000-00004 |
0.334 |
|
| 1998 |
Henry TR, Buchtel HA, Koeppe RA, Pennell PB, Kluin KJ, Minoshima S. Absence of normal activation of the left anterior fusiform gyrus during naming in left temporal lobe epilepsy. Neurology. 50: 787-90. PMID 9521277 DOI: 10.1212/Wnl.50.3.787 |
0.307 |
|
| 1997 |
Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001 |
0.306 |
|
| 1997 |
Johnson-Greene D, Adams KM, Gilman S, Koeppe RA, Junck L, Kluin KJ, Martorello S, Heumann M. Effects of abstinence and relapse upon neuropsychological function and cerebral glucose metabolism in severe chronic alcoholism. Journal of Clinical and Experimental Neuropsychology. 19: 378-85. PMID 9268812 DOI: 10.1080/01688639708403866 |
0.337 |
|
| 1997 |
Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology (Baltimore, Md.). 26: 277-82. PMID 9252134 DOI: 10.1002/Hep.510260204 |
0.392 |
|
| 1996 |
Liberzon I, Taylor SF, Fig LM, Koeppe RA. Alteration of corticothalamic perfusion ratios during a PTSD flashback. Depression and Anxiety. 4: 146-50. PMID 9166645 DOI: 10.1002/(Sici)1520-6394(1996)4:3<146::Aid-Da9>3.0.Co;2-E |
0.326 |
|
| 1996 |
Gilman S, Frey KA, Koeppe RA, Junck L, Little R, Vander Borght TM, Lohman M, Martorello S, Lee LC, Jewett DM, Kilbourn MR. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Annals of Neurology. 40: 885-92. PMID 9007093 DOI: 10.1002/Ana.410400610 |
0.35 |
|
| 1996 |
Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/Ana.410400609 |
0.376 |
|
| 1996 |
Gilman S, Sima AA, Junck L, Kluin KJ, Koeppe RA, Lohman ME, Little R. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Annals of Neurology. 39: 241-55. PMID 8967756 DOI: 10.1002/Ana.410390214 |
0.32 |
|
| 1996 |
Gilman S, Adams KM, Johnson-Greene D, Koeppe RA, Junck L, Kluin KJ, Martorello S, Heumann M, Hill E. Effects of disulfiram on positron emission tomography and neuropsychological studies in severe chronic alcoholism. Alcoholism, Clinical and Experimental Research. 20: 1456-61. PMID 8947325 DOI: 10.1111/J.1530-0277.1996.Tb01149.X |
0.37 |
|
| 1996 |
Casey KL, Minoshima S, Morrow TJ, Koeppe RA. Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. Journal of Neurophysiology. 76: 571-81. PMID 8836245 DOI: 10.1152/Jn.1996.76.1.571 |
0.306 |
|
| 1996 |
Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology. 40: 399-410. PMID 8797529 DOI: 10.1002/Ana.410400309 |
0.381 |
|
| 1996 |
Gilman S, Koeppe RA, Adams K, Johnson-Greene D, Junck L, Kluin KJ, Brunberg J, Martorello S, Lohman M. Positron emission tomographic studies of cerebral benzodiazepine- receptor binding in chronic alcoholics Annals of Neurology. 40: 163-171. PMID 8773597 DOI: 10.1002/Ana.410400207 |
0.315 |
|
| 1996 |
Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007 |
0.327 |
|
| 1996 |
Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 303-10. PMID 8594063 DOI: 10.1097/00004647-199603000-00016 |
0.36 |
|
| 1996 |
Berent S, Giordani B, Gilman S, Junck L, Kluin KJ, Koeppe RA. Psychological Factors and Pet Measured Glucose Metabolism in Olivopontocerebellar Atrophy Assessment. 3: 339-349. DOI: 10.1177/1073191196003003013 |
0.342 |
|
| 1996 |
Awh E, Jonides J, Smith EE, Schumacher EH, Koeppe RA, Katz S. Dissociation of Storage and Rehearsal in Verbal Working Memory: Evidence from Positron Emission Tomography Psychological Science. 7: 25-31. DOI: 10.1111/J.1467-9280.1996.Tb00662.X |
0.31 |
|
| 1996 |
Lauber EJ, Meyer DE, Evans JE, Rubinstein J, Gmeindl L, Junck L, Koeppe RA. The brain areas involved in the executive control of task switching as revealed by PET Neuroimage. 3. DOI: 10.1016/S1053-8119(96)80249-7 |
0.305 |
|
| 1995 |
Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Archives of Neurology. 52: 314-7. PMID 7872887 DOI: 10.1001/Archneur.1995.00540270110027 |
0.374 |
|
| 1995 |
Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, Hernandez RJ, Koeppe RA, Hutchinson RJ. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology. 194: 495-500. PMID 7824731 DOI: 10.1148/Radiology.194.2.7824731 |
0.342 |
|
| 1995 |
Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nuclear Medicine and Biology. 22: 13-7. PMID 7735163 DOI: 10.1016/0969-8051(94)00082-U |
0.308 |
|
| 1995 |
Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, Laurent RTS. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography Annals of Neurology. 38: 176-185. PMID 7654065 DOI: 10.1002/Ana.410380209 |
0.342 |
|
| 1995 |
Gilman S, Laurent RTS, Koeppe RA, Junck L, Kluin KJ, Lohman M. A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology. 45: 1345-1352. PMID 7617196 DOI: 10.1212/Wnl.45.7.1345 |
0.351 |
|
| 1995 |
Adams KM, Gilman S, Koeppe R, Kluin K, Junck L, Lohman M, Johnson-Greene DE, Berent S, Dede D, Kroll P. Correlation of Neuropsychological Function With Cerebral Metabolic Rate in Subdivisions of the Frontal Lobes of Older Alcoholic Patients Measured With [18F]Fluorodeoxyglucose and Positron Emission Tomography Neuropsychology (Journal). 9: 275-280. DOI: 10.1037/0894-4105.9.3.275 |
0.344 |
|
| 1994 |
Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 85-99. PMID 8263062 DOI: 10.1038/Jcbfm.1994.13 |
0.321 |
|
| 1994 |
Casey KL, Minoshima S, Berger KL, Koeppe RA, Morrow TJ, Frey KA. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. Journal of Neurophysiology. 71: 802-7. PMID 8176441 DOI: 10.1152/Jn.1994.71.2.802 |
0.337 |
|
| 1994 |
Junck L, Gilman S, Gebarski SS, Koeppe RA, Kluin KJ, Markel DS. Structural and functional brain imaging in Friedreich's ataxia Jama Neurology. 51: 349-355. PMID 8155012 DOI: 10.1001/Archneur.1994.00540160043007 |
0.343 |
|
| 1994 |
Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, Laurent RTS. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy Annals of Neurology. 36: 166-175. PMID 8053652 DOI: 10.1002/Ana.410360208 |
0.368 |
|
| 1994 |
Cameron OG, Zubieta JK, Minoshima S, Koeppe R. Effects of yohimbine on cerebral blood flow in humans: a pet study Biological Psychiatry. 35: 646-647. DOI: 10.1016/0006-3223(94)90773-0 |
0.3 |
|
| 1993 |
Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. Journal of Neurochemistry. 60: 2315-8. PMID 8492135 DOI: 10.1111/J.1471-4159.1993.Tb03521.X |
0.359 |
|
| 1993 |
Adams KM, Gilman S, Koeppe RA, Kluin KJ, Brunberg JA, Dede D, Berent S, Kroll PD. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcoholism, Clinical and Experimental Research. 17: 205-10. PMID 8488956 DOI: 10.1111/J.1530-0277.1993.Tb00750.X |
0.38 |
|
| 1993 |
Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology. 186: 711-715. PMID 8430179 DOI: 10.1148/Radiology.186.3.8430179 |
0.342 |
|
| 1993 |
Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, Ross DA, Berent S, Young AB, Kuhl DE. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 43: 1998-2006. PMID 8413957 DOI: 10.1212/Wnl.43.10.1998 |
0.321 |
|
| 1993 |
Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, Young AB. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Annals of Neurology. 34: 76-81. PMID 8390806 DOI: 10.1002/Ana.410340114 |
0.352 |
|
| 1993 |
Taylor S, Kornblum S, Minoshima S, Oliver L, Koeppe R, Agranoff B. Cerebral blood flow activation of the anterior cingulate gyrus studied with positron emission tomography Schizophrenia Research. 9: 210. DOI: 10.1016/0920-9964(93)90452-O |
0.319 |
|
| 1992 |
Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW. In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 12: 147-54. PMID 1727135 DOI: 10.1038/Jcbfm.1992.18 |
0.355 |
|
| 1992 |
Foster NL, Gilman S, Berent S, Sima AA, D'Amato C, Koeppe RA, Hicks SP. Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 707-13. PMID 1527543 DOI: 10.1136/Jnnp.55.8.707 |
0.367 |
|
| 1992 |
Koeppe RA, Hutchins GD. Instrumentation for positron emission tomography: Tomographs and data processing and display systems Seminars in Nuclear Medicine. 22: 162-181. PMID 1523414 DOI: 10.1016/S0001-2998(05)80144-8 |
0.314 |
|
| 1992 |
Boivin MJ, Giordani B, Berent S, Amato DA, Lehtinen S, Koeppe RA, Buchtel HA, Foster NL, Kuhl DE. Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 28: 231-9. PMID 1499309 DOI: 10.1016/S0010-9452(13)80051-2 |
0.375 |
|
| 1991 |
Koeppe RA, Shulkin BL, Rosenspire KC, Shaw LA, Betz AL, Mangner T, Price JC, Agranoff BW. Effect of aspartame-derived phenylalanine on neutral amino acid uptake in human brain: a positron emission tomography study. Journal of Neurochemistry. 56: 1526-35. PMID 2013754 DOI: 10.1111/J.1471-4159.1991.Tb02047.X |
0.331 |
|
| 1991 |
Holthoff VA, Koeppe RA, Frey KA, Paradise AH, Kuhl DE. Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 745-52. PMID 1874806 DOI: 10.1038/Jcbfm.1991.131 |
0.361 |
|
| 1991 |
Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Annals of Neurology. 30: 663-72. PMID 1662476 DOI: 10.1002/Ana.410300506 |
0.317 |
|
| 1991 |
Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 735-44. PMID 1651944 DOI: 10.1038/Jcbfm.1991.130 |
0.307 |
|
| 1990 |
Koeppe RA, Mangner T, Betz AL, Shulkin BL, Allen R, Kollros P, Kuhl DE, Agranoff BW. Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 10: 727-39. PMID 2384544 DOI: 10.1038/Jcbfm.1990.126 |
0.328 |
|
| 1990 |
Giordani B, Boivin MJ, Berent S, Betley AT, Koeppe RA, Rothley JM, Modell JG, Hichwa RD, Kuhl DE. Anxiety and cerebral cortical metabolism in normal persons. Psychiatry Research. 35: 49-60. PMID 2367610 DOI: 10.1016/0925-4927(90)90008-T |
0.34 |
|
| 1990 |
Cameron OG, Modell JG, Hichwa RD, Agranoff BW, Koeppe RA. Changes in sensory-cognitive input: effects on cerebral blood flow. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 10: 38-42. PMID 2298835 DOI: 10.1038/Jcbfm.1990.5 |
0.334 |
|
| 1990 |
Gilman S, Adams K, Koeppe RA, Berent S, Kluin KJ, Modell JG, Kroll P, Brunberg JA. Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Annals of Neurology. 28: 775-85. PMID 2285264 DOI: 10.1002/Ana.410280608 |
0.339 |
|
| 1990 |
Gilman S, Junck L, Markel DS, Koeppe RA, Kluin KJ. Cerebral glucose hypermetabolism in Friedreich's ataxia detected with positron emission tomography Annals of Neurology. 28: 750-757. PMID 2285262 DOI: 10.1002/Ana.410280605 |
0.366 |
|
| 1989 |
Kilbourn MR, Carey JE, Koeppe RA, Haka MS, Hutchins GD, Sherman PS, Kuhl DE. Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 16: 569-76. PMID 2606712 DOI: 10.1016/0883-2897(89)90072-X |
0.333 |
|
| 1989 |
Junck L, Olson JM, Ciliax BJ, Koeppe RA, Watkins GL, Jewett DM, McKeever PE, Wieland DM, Kilbourn MR, Starosta-Rubinstein S. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Annals of Neurology. 26: 752-8. PMID 2557794 DOI: 10.1002/Ana.410260611 |
0.316 |
|
| 1988 |
Rosenthal G, Gilman S, Koeppe RA, Kluin KJ, Markel DS, Junck L, Gebarski SS. Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography. Annals of Neurology. 24: 414-419. PMID 3265863 DOI: 10.1002/Ana.410240310 |
0.349 |
|
| 1988 |
Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Annals of Neurology. 24: 399-406. PMID 3265862 DOI: 10.1002/Ana.410240308 |
0.378 |
|
| 1988 |
Junck L, Gilman S, Rothley JR, Betley AT, Koeppe RA, Hichwa RD. A relationship between metabolism in frontal lobes and cerebellum in normal subjects studied with PET Journal of Cerebral Blood Flow and Metabolism. 8: 774-782. PMID 3263982 DOI: 10.1038/Jcbfm.1988.132 |
0.336 |
|
| 1988 |
Kluin KJ, Gilman S, Markel DS, Koeppe RA, Rosenthal G, Junck L. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings Annals of Neurology. 23: 547-554. PMID 3261572 DOI: 10.1002/Ana.410230604 |
0.361 |
|
| 1988 |
Gilman S, Markel DS, Koeppe RA, Junck L, Kluin KJ, Gebarski SS, Hichwa RD. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography Annals of Neurology. 23: 223-230. PMID 3259853 DOI: 10.1002/Ana.410230303 |
0.399 |
|
| Show low-probability matches. |